Prescription drug · ANDA
Sacubitril and Valsartan NDC 71610-982
Sacubitril 49 mg/1; Valsartan 51 mg/1 · Tablet · Oral · Aphena Pharma Solutions - Tennessee, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71610-982-89 | 7161009828971610098289 | 720 TABLET in 1 BOTTLE (71610-982-89)Marketed from Jan 14, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Sacubitril and Valsartan
- Generic name (nonproprietary)
- sacubitril and valsartan
- Active ingredients
- Sacubitril — 49 mg/1Valsartan — 51 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Aphena Pharma Solutions - Tennessee, LLCNDC labeler code 71610
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 213728
- Marketing start
- Listing expires
- Other FDA classes
- Angiotensin 2 Receptor Antagonists (Mechanism)Neprilysin Inhibitors (Mechanism)
- Identifiers
- Product ID 71610-982_48714aae-1dc8-dd89-e063-6294a90a73e6SPL ID 48714aae-1dc8-dd89-e063-6294a90a73e6SPL set ID 48714b95-b4ac-ef3c-e063-6294a90a9a5bRxCUI 1656349UNII 17ERJ0MKGI, 80M03YXJ7I
- Pharmacologic class
- Angiotensin 2 Receptor Blocker; Neprilysin Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471610098289followed by a unit qualifier and the quantityPackage 71610-0982-89. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Sacubitril and valsartan tablets are a combination of sacubitril, a neprilisin inhibitor, and valsartan, an angiotensin II receptor blocker, and sacubitril and valsartan tablets are indicated: • to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure. Benefits are most clearly evident in patients with left ventricular ejection fraction (LVEF) below normal. ( 1.1 ) • for the treatment of symptomatic heart failure with systemic left ventricular systolic dysfunction in pediatric patients aged one year and older. Sacubitril and Valsartan reduces NT-proBNP and is expected to improve cardiovascular outcomes. ( 1.2 ) 1.1 Adult He…
Excerpt only. Read the full label for complete information.
About NDC 71610-982
- What is NDC 71610-982?
- 71610-982 is the product NDC for Sacubitril and Valsartan, Sacubitril 49 mg/1; Valsartan 51 mg/1 tablet, listed with the FDA by Aphena Pharma Solutions - Tennessee, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Sacubitril and Valsartan.
- What is the active ingredient?
- Sacubitril, Valsartan.
- Who is the labeler?
- Aphena Pharma Solutions - Tennessee, LLC, NDC labeler code 71610. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Sacubitril and Valsartan?
- 89 other product NDCs are listed under this name. See all Sacubitril and Valsartan NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Sacubitril and Valsartan products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Sacubitril and Valsartan | Sacubitril 49 mg/1; Valsartan 51 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | 84386-082 | 84386-0082-1884386-0082-6084386-0082-78 |
| Sacubitril and Valsartan | Sacubitril 24 mg/1; Valsartan 26 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | 84386-081 | 84386-0081-1884386-0081-6084386-0081-78 |
| Sacubitril and Valsartan | Sacubitril 97 mg/1; Valsartan 103 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | 84386-083 | 84386-0083-1884386-0083-6084386-0083-78 |
| Sacubitril and Valsartan | Sacubitril 97 mg/1; Valsartan 103 mg/1 | Tablet, Film coatedOral | Umedica Laboratories USA Inc. | 60290-087 | 60290-0087-0160290-0087-0260290-0087-03 |
| Sacubitril and Valsartan | Sacubitril 24 mg/1; Valsartan 26 mg/1 | Tablet, Film coatedOral | Umedica Laboratories USA Inc. | 60290-085 | 60290-0085-0160290-0085-0260290-0085-03 |
| Sacubitril and Valsartan | Sacubitril 49 mg/1; Valsartan 51 mg/1 | Tablet, Film coatedOral | Umedica Laboratories USA Inc. | 60290-086 | 60290-0086-0160290-0086-0260290-0086-03 |
| Sacubitril and Valsartan | Sacubitril 24 mg/1; Valsartan 26 mg/1 | Tablet, Film coatedOral | NorthStar RxLLC | 72603-880 | 72603-0880-0172603-0880-02 |
| Sacubitril and Valsartan | Sacubitril 49 mg/1; Valsartan 51 mg/1 | Tablet, Film coatedOral | NorthStar RxLLC | 72603-881 | 72603-0881-0172603-0881-02 |
| Sacubitril and Valsartan | Sacubitril 97 mg/1; Valsartan 103 mg/1 | Tablet, Film coatedOral | NorthStar RxLLC | 72603-882 | 72603-0882-0172603-0882-02 |
| sacubitril and valsartan | Sacubitril 97 mg/1; Valsartan 103 mg/1 | Tablet, Film coatedOral | Golden State Medical Supply, Inc. | 51407-937 | 51407-0937-10 |
Other NDCs under ANDA 213728
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Sacubitril and Valsartan | Sacubitril 24 mg/1; Valsartan 26 mg/1 | TabletOral | Macleods Pharmaceuticals Limited | 33342-570 |
| Sacubitril and Valsartan | Sacubitril 49 mg/1; Valsartan 51 mg/1 | TabletOral | Macleods Pharmaceuticals Limited | 33342-571 |
| Sacubitril and Valsartan | Sacubitril 97 mg/1; Valsartan 103 mg/1 | TabletOral | Macleods Pharmaceuticals Limited | 33342-572 |
| Sacubitril and Valsartan | Sacubitril 24 mg/1; Valsartan 26 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-983 |
| Sacubitril and Valsartan | Sacubitril 97 mg/1; Valsartan 103 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-984 |
| Sacubitril and Valsartan | Sacubitril 24 mg/1; Valsartan 26 mg/1 | Tablet, Film coatedOral | NorthStar RxLLC | 72603-880 |
| Sacubitril and Valsartan | Sacubitril 49 mg/1; Valsartan 51 mg/1 | Tablet, Film coatedOral | NorthStar RxLLC | 72603-881 |
| Sacubitril and Valsartan | Sacubitril 97 mg/1; Valsartan 103 mg/1 | Tablet, Film coatedOral | NorthStar RxLLC | 72603-882 |
| Sacubitril and Valsartan | Sacubitril 24 mg/1; Valsartan 26 mg/1 | TabletOral | XLCare Pharmaceuticals Inc | 72865-310 |
| Sacubitril and Valsartan | Sacubitril 49 mg/1; Valsartan 51 mg/1 | TabletOral | XLCare Pharmaceuticals Inc | 72865-311 |
| Sacubitril and Valsartan | Sacubitril 97 mg/1; Valsartan 103 mg/1 | TabletOral | XLCare Pharmaceuticals Inc | 72865-312 |